Skip to Content

Tamoxifen Tablets

Last Updated: May 12, 2015
Status: Resolved

Products Affected - Description

There are no affected products.

Reason for the Shortage

  • Teva could not provide a reason for the shortage.
  • Mylan discontinued tamoxifen 10 mg 500 count and 20 mg 100 count presentations.
  • Actavis could not provide a reason for the shortage.

Available Products

Tamoxifen tablets, Actavis
10 mg, 60 count (NDC 00591-2472-60)
10 mg, 180 count (NDC 00591-2472-18)

20 mg, 30 count (NDC 00591-2473-30)
20 mg, 90 count (NDC 00591-2473-19)
 
Tamoxifen tablets, Mylan
10 mg, 60 count (NDC 00378-0144-91)
20 mg, 30 count (NDC 00378-0274-93)
 
Tamoxifen tablets, Teva
10 mg, 60 count (NDC 00093-0784-06)
10 mg, 180 count (NDC 00093-0784-86)
10 mg, 500 count (NDC 00093-0784-05)
10 mg, 1000 count (NDC 00093-0784-10)
20 mg, 30 count (NDC 00093-0782-56)
20 mg, 100 count (NDC 00093-0782-01)
20 mg, 500 count (NDC 00093-0782-05)
20 mg, 1000 count (NDC 00093-0782-10)

Estimated Resupply Dates

All presentations are available.

Related Shortages

Updated

May 12, March 10, January 7, 2015; October 22, August 4, May 9 and 29, April 3 and 15, March 6, January 7, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide